Ictero Medical plans first human studies after raising $6M from MedTex, S3

A Houston-based medical device company plans to pursue its first human studies after an injection of financing. In late April, Ictero Medical Inc. announced raising $6 million in Series A financing led by Connecticut-based MedTex Ventures, Austin-based S3 Ventures and an undisclosed strategic investor. Ictero is developing a device for high-risk patients with gallbladder disease. The company has shown in a nimal models that the device is able to ablate the functions of the gallbladder with extreme…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news